UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Collaborations in Dietetics Education across Countries

Journal of the Academy of Nutrition and Dietetics, 2016-09, Vol.116 (9), p.A68-A68

2016

Volltextzugriff (PDF)

Prognostic Importance of Pathological Fractures in Osteosarcomas

Irish medical journal, 2020-12, Vol.112 (10), p.1021

2020

Volltextzugriff (PDF)

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Annals of oncology, 2018-10, Vol.29, p.viii240-viii241

2018

Volltextzugriff (PDF)

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

European journal of cancer (1990), 2015-09, Vol.51, p.S477-S478

2015

Volltextzugriff (PDF)

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

HPB (Oxford, England), 2023, Vol.25, p.S560-S561

2023

Volltextzugriff (PDF)

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

Current oncology (Toronto), 2020-11, Vol.27 (13), p.165

2020

Volltextzugriff (PDF)

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S420-S420

2021

Volltextzugriff (PDF)

Distraction by Competing Speech in Young and Older Adult Listeners

Psychology and aging, 2002-09, Vol.17 (3), p.453-467

2002

Volltextzugriff (PDF)

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S587-S587

2018

Volltextzugriff (PDF)

Cascade testing following universal immunohistochemistry for mismatch repair protiens

Annals of oncology, 2016-10, Vol.27, p.vi186-vi186

2016

Volltextzugriff (PDF)

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

Radiotherapy and oncology, 2020-11, Vol.152, p.S230-S231

2020

Volltextzugriff (PDF)

Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: a propensity score matched study

HPB (Oxford, England), 2024, Vol.26, p.S110-S111

2024

Volltextzugriff (PDF)

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.S44-S45

2018

Volltextzugriff (PDF)

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S820-S821

2018

Volltextzugriff (PDF)

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S675-S675

2021

Volltextzugriff (PDF)

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S420-S421

2018

Volltextzugriff (PDF)

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S476-S477

2018

Volltextzugriff (PDF)

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S586-S586

2018

Volltextzugriff (PDF)

712PMolecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Irish medical journal, 2016-03, Vol.109 (3), p.375-375

2016

Volltextzugriff (PDF)

Longitudinal Health Utilities, Symptoms and Toxicities in Patients with ALK-Rearranged Lung Cancer Treated with Tyrosine Kinase Inhibitors: A Prospective Real-World Assessment

Current oncology (Toronto), 2020-12, Vol.27 (6), p.552

2020

Volltextzugriff (PDF)

Vismodegib in the treatment of advanced BCC

Irish medical journal, 2014-07, Vol.107 (7), p.215-216

2014

Volltextzugriff (PDF)

P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria

Annals of oncology, 2022-06, Vol.33, p.S308

2022

Volltextzugriff (PDF)

What right to private property?

Economy and society, 1997-11, Vol.26 (4), p.456-479

O'Kane, Stephen G.

1997

Volltextzugriff (PDF)

Triple negative breast cancers: comparative study of clinical features and overall survival in an Irish population

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2083

2009

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieIrish Journal Of Medical Science

Zeitschrift / SerieMaterials Research Bulletin

ThemaCardiovascular System & Cardiology

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(160)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(26)
Biological And Medical Sciences
(18)
Male
(15)
Adult
(11)
Female
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Medical Sciences
(9)
Middle Aged
(9)
Aged
(7)
Animals
(5)
Social Sciences
(5)
Bioluminescence
(4)
Luminescence
(4)
Pharmacology. Drug Treatments
(4)
Adolescent
(3)
Aged, 80 And Over
(3)
Basidiomycotina
(3)
Biochemie
(3)
Biochemistry
(3)
Blood Pressure
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Collaborations in Dietetics Education across Countries

Prognostic Importance of Pathological Fractures in Osteosarcomas

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Distraction by Competing Speech in Young and Older Adult Listeners

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Cascade testing following universal immunohistochemistry for mismatch repair protiens

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: a propensity score matched study

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

712PMolecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Longitudinal Health Utilities, Symptoms and Toxicities in Patients with ALK-Rearranged Lung Cancer Treated with Tyrosine Kinase Inhibitors: A Prospective Real-World Assessment

Vismodegib in the treatment of advanced BCC

P-162 Atezolizumab and bevacizumab pre-liver transplantation for patients with hepatocellular carcinoma beyond Milan criteria

What right to private property?

Triple negative breast cancers: comparative study of clinical features and overall survival in an Irish population

Aktive Filter

Suchergebnisse filtern